Stifel Financial Corp Has $4.48 Million Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Stifel Financial Corp lessened its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 5.0% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 500,266 shares of the pharmacy operator’s stock after selling 26,170 shares during the period. Stifel Financial Corp’s holdings in Walgreens Boots Alliance were worth $4,482,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Assenagon Asset Management S.A. raised its holdings in shares of Walgreens Boots Alliance by 4.0% in the 2nd quarter. Assenagon Asset Management S.A. now owns 27,699 shares of the pharmacy operator’s stock worth $335,000 after acquiring an additional 1,069 shares during the last quarter. Blue Trust Inc. raised its stake in shares of Walgreens Boots Alliance by 87.0% in the second quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 1,081 shares during the last quarter. Gradient Investments LLC lifted its holdings in shares of Walgreens Boots Alliance by 530.2% in the second quarter. Gradient Investments LLC now owns 3,403 shares of the pharmacy operator’s stock valued at $41,000 after purchasing an additional 2,863 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. boosted its position in shares of Walgreens Boots Alliance by 6.1% during the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 2,718,659 shares of the pharmacy operator’s stock valued at $32,882,000 after buying an additional 156,484 shares during the last quarter. Finally, MONECO Advisors LLC bought a new stake in Walgreens Boots Alliance during the second quarter worth $182,000. Institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Performance

NASDAQ:WBA opened at $10.39 on Monday. The company has a market capitalization of $8.98 billion, a P/E ratio of -1.04, a P/E/G ratio of 1.36 and a beta of 0.66. The business has a fifty day simple moving average of $9.27 and a two-hundred day simple moving average of $10.69. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.68 and a quick ratio of 0.37. Walgreens Boots Alliance, Inc. has a 1 year low of $8.08 and a 1 year high of $27.05.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.03. The company had revenue of $37.50 billion during the quarter, compared to analyst estimates of $35.75 billion. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The firm’s revenue for the quarter was up 5.9% on a year-over-year basis. During the same quarter last year, the firm posted $0.67 EPS. On average, analysts expect that Walgreens Boots Alliance, Inc. will post 1.53 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, December 12th. Investors of record on Monday, November 18th were issued a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 9.62%. The ex-dividend date of this dividend was Monday, November 18th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently -9.99%.

Wall Street Analyst Weigh In

WBA has been the topic of a number of analyst reports. Jefferies Financial Group cut their price objective on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a report on Wednesday, October 23rd. Truist Financial cut their price target on shares of Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating on the stock in a report on Monday, October 7th. JPMorgan Chase & Co. decreased their price objective on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating for the company in a research note on Friday, August 30th. Morgan Stanley cut their target price on Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating on the stock in a research note on Friday, October 11th. Finally, UBS Group increased their price target on Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a research report on Thursday, October 17th. Four investment analysts have rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $12.58.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.